Characterization of the neutralizing activity of digoxin-specific fab toward ouabain-like steroids

被引:43
作者
Pullen, MA [1 ]
Brooks, DP [1 ]
Edwards, RM [1 ]
机构
[1] GlaxoSmithKline Pharmaceut, Dept Renal Biol, King Of Prussia, PA USA
关键词
D O I
10.1124/jpet.104.065250
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Digoxin-specific Fab ( Digibind) is a mixture of antidigoxin Fab fragments prepared from sheep sera and is used as a treatment for digoxin poisoning. Digoxin-specific Fab has been shown to neutralize an endogenous Na+/K+ ATPase inhibitor ( endogenous digoxin-like Na+/K+ ATPase regulatory factor; EDLF) in rats and humans and to lower blood pressure. Although the exact structure of EDLF is unknown, compounds identical to or structurally related to ouabain, bufalin, and marinobufagenin have been detected in mammalian plasma. In this study, some structural characteristics of EDLF were inferred from the ability of digoxin-specific Fab to neutralize the Na+/K+ ATPase inhibitory activity of several known cardenolides and bufodienolides. Additional structural information was obtained from [H-3]ouabain binding and enzyme-linked immunosorbent assay experiments. Digoxin-specific Fab had the ability to interact to some extent with all of the cardenolides and bufodienolides tested. However, digoxin-specific Fab was more than 20-fold more potent in neutralizing ouabain and bufalin than marinobufagenin. The antihypertensive effect of digoxin-specific Fab seen in preeclampsia and animal models of hypertension may therefore be due to a molecule identical to or structurally similar to ouabain or bufalin.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 40 条
[11]   EVIDENCE FOR AN ENDOGENOUS OUABAIN-LIKE IMMUNOREACTIVE FACTOR IN HUMAN NEWBORN PLASMA COELUTED WITH OUABAIN ON HPLC [J].
DIBARTOLO, V ;
BALZAN, S ;
PIERACCINI, L ;
GHIONE, S ;
PEGORARO, S ;
BIVER, P ;
REVOLTELLA, R ;
MONTALI, U .
LIFE SCIENCES, 1995, 57 (15) :1417-1425
[12]  
El-Masri MA, 2002, CLIN CHEM, V48, P1720
[13]   Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis [J].
Farr, CD ;
Tabet, MR ;
Ball, WJ ;
Fishwild, DM ;
Wang, X ;
Nair, AC ;
Welsh, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (15) :3257-3270
[14]   Three-dimensional quantitative structure -: Activity relationship study of the inhibition of Na+,K+-ATPase by cardiotonic steroids using comparative molecular field analysis [J].
Farr, CD ;
Burd, C ;
Tabet, MR ;
Wang, X ;
Welsh, WJ ;
Ball, WJ .
BIOCHEMISTRY, 2002, 41 (04) :1137-1148
[15]   Marinobufagenin, an endogenous α-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats [J].
Fedorova, OV ;
Kolodkin, NI ;
Agalakova, NI ;
Lakatta, EG ;
Bagrov, AY .
HYPERTENSION, 2001, 37 (02) :462-466
[16]   Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin - Evidence of interaction with different alpha-subunit isoforms [J].
Fedorova, OV ;
Bagrov, AY .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (08) :929-935
[18]   Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity [J].
Fridman, AI ;
Matveev, SA ;
Agalakova, NI ;
Fedorova, OV ;
Lakatta, EG ;
Bagrov, AY .
JOURNAL OF HYPERTENSION, 2002, 20 (06) :1189-1194
[19]  
GOODLIN RC, 1988, NEW ENGL J MED, V318, P518
[20]   DIGITALIS-LIKE FACTOR AND DIGOXIN-LIKE IMMUNOREACTIVE FACTOR IN DIABETIC WOMEN WITH PREECLAMPSIA, TRANSIENT HYPERTENSION OF PREGNANCY, AND NORMOTENSIVE PREGNANCY [J].
GRAVES, SW ;
LINCOLN, K ;
COOK, SL ;
SEELY, EW .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (01) :5-11